Lilly Japan Suffers Negative Growth for 3rd Straight Year in 2022 as 2 Major LOEs Weigh

Eli Lilly Japan President Simone Thomsen (left); Akikazu Yoshikawa, Senior Vice President, Japan Drug Development & Medical Affairs Eli Lilly Japan incurred negative sales growth for the third year running in 2022 as it faced a lingering blow from the...read more